GE Healthcare Life Sciences will be providing its ImageQuant LAS4000 biomolecular imager to the antidoping team at the London 2012 Olympic Games and Paralympic Games.
The biomolecular imager will be a crucial part of the testing process for the performance-enhancing drug recombinant erythropoietin (EPO), GE said.
